30Apr 2023
Use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock

Use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock

Despite its high incidence and mortality risk, there is no evidence‐based non‐ischaemic cardiogenic shock (CS) treatment. Therefore, this study aimed to evaluate mechanical circulatory support (MCS) use for non‐ischaemic CS treatment. Patients treated with MCS presented with more severe CS (37% vs 23% deteriorating CS, 30% vs 25% in extremis CS) and had a lower left ventricular ejection fraction at baseline (21% vs 25%). In patients with non‐ischaemic CS, MCS use was associated with lower 30‐day mortality compared to medical therapy but also with more complications.

  • #cardiology

Like

Save

Share